IgG4-related disease: about 3 cases

• Published in: The Pan African medical journal 2020-08, Vol.36, p.364
• Main Authors: Abid, Hakima, Alaoui, Moulaye El Hacen Horma Babana El, Lamrani, Moulay Youssef Alaoui, Figuigui, Mouna, Ahmed, Beiba Cheikh, Lahmidani, Nada, Yousfi, Mounia El, Benajah, Dafr-Allah, Maaroufi, Mustapha, Abkari, Mohammed El, Ibrahimi, Sidi Adil, Aqodad, Nourdin
• Format: Article
• Language: fre
• Subjects: Adrenal Cortex Hormones - therapeutic use; Aged, 80 and over; Humans; Immunoglobulin G4-Related Disease - diagnosis; Immunoglobulin G4-Related Disease - physiopathology; Immunoglobulin G4-Related Disease - therapy; Immunologic Factors - therapeutic use; Male; Middle Aged
• ISSN: 1937-8688
• DOI: 10.11604/pamj.2020.36.364.24835

IgG4-Related disease (IgG4-RD), formerly known as IgG4-related autoimmune polyexocrinopathy, is a new condition including Plasminogen Activator Inhibitor-1 (PAI-1). It can affect different organs (central nervous system, salivary glands, thyroid, lungs, pancreas, bile ducts, liver, digestive tract, kidneys, prostate, etc.) with symptoms depending on the organ that is affected. It is more common in men older than 50 years of age. Its incidence and prevalence are poorly known because it is an uncommon disease. It is most common in Asia, accounting for only 20-30% of PAI in the Western world. Diagnosis is based on histological examination which shows dense lymphoplasmocytic infiltration in the organ affected associated with IgG4-positive plasma cells (immunohistochemistry), organ fibrosis and obliterating venulitis, all this in the context of increased serum IgG4 levels in more than 80% of cases. Patients are sensitive to corticosteroid therapy, with a high risk of relapse after discontinuation of corticosteroid therapy. This leads to the use of immunomodulators, mainly: thiopurines (azathioprine or 6-mercaptopurine), methotrexate and more recently rituximab, which can also be used as induction therapy. Given recent advances, accurate histological and clinical criteria are currently known to limit inappropriate management such as surgery. However, knowledge gaps remain concerning: pathophysiology, identification of specific biomarkers other than IgG4, natural history of the disease and long-term cancer risk assessment, performances of diagnostic tools such as endoscopic ultrasound-guided pancreatic biopsy. As well, consensual international management should be defined in the early stages of the disease and when patients develop recurrences. The purpose of this study was to report 3 cases of IgG4-Related disease on the basis of clinical and radiological criteria as well as therapeutic response.